MeVis Medical Solutions AG Total Assets
MeVis Medical Solutions AG total assets. Based on the latest financial reports, MeVis Medical Solutions AG (M3V) holds total assets worth €23.16 Million EUR (≈ $27.08 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is MeVis Medical Solutions AG worth for the company's overall valuation and market capitalisation.
Total Assets of MeVis Medical Solutions AG (2006–2025)
Total assets of MeVis Medical Solutions AG from 2006 to 2025. This chart illustrates how MeVis Medical Solutions AG's total assets have evolved over time, based on quarterly financial data. See MeVis Medical Solutions AG (M3V) share price today for real-time trading data and today's change.
MeVis Medical Solutions AG - Asset Composition Analysis
MeVis Medical Solutions AG Total Assets Breakdown (September 2025)
MeVis Medical Solutions AG total assets breakdown as of September 2025. MeVis Medical Solutions AG's total assets of €23.16 Million consist of 35.0% current assets and 65.0% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 25.2% |
| Accounts Receivable | €2.28 Million | 8.8% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €308.77K | 1.2% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how MeVis Medical Solutions AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore MeVis Medical Solutions AG (M3V) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MeVis Medical Solutions AG's current assets represent 35.0% of total assets in 2025, a decrease from 86.3% in 2006.
- Cash Position: Cash and equivalents constituted 25.2% of total assets in 2025, down from 59.6% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 8.8% of total assets.
MeVis Medical Solutions AG Competitors by Total Assets
Key competitors of MeVis Medical Solutions AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Heartflow, Inc. Common Stock
NASDAQ:HTFL
|
USA | $364.40 Million |
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥228.40 Million |
|
Doctor Care Anywhere Group Plc
AU:DOC
|
Australia | AU$15.02 Million |
|
KDA Group Inc
V:KDA
|
Canada | CA$9.20 Million |
|
MEDAPP S.A. ZY -10
F:WQ1
|
Germany | €39.88 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
MeVis Medical Solutions AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.27 | 1.67 | 1.80 |
| Quick Ratio | 2.27 | 1.67 | 1.80 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €3.72 Million | €2.72 Million | €3.41 Million |
MeVis Medical Solutions AG - Advanced Valuation Insights
This section examines the relationship between MeVis Medical Solutions AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.41 |
| Latest Market Cap to Assets Ratio | 1.66 |
| Asset Growth Rate (YoY) | -2.3% |
| Total Assets | €25.89 Million |
| Market Capitalization | $42.95 Million USD |
Valuation Analysis
Above Book Valuation: The market values MeVis Medical Solutions AG's assets above their book value (1.66x), reflecting positive investor sentiment about the company's future prospects.
Slight Asset Contraction: MeVis Medical Solutions AG's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for MeVis Medical Solutions AG (2006–2025)
The table below shows the annual total assets of MeVis Medical Solutions AG from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | €25.89 Million ≈ $30.26 Million |
-2.26% |
| 2024-09-30 | €26.48 Million ≈ $30.96 Million |
-5.60% |
| 2023-09-30 | €28.05 Million ≈ $32.80 Million |
-10.09% |
| 2022-09-30 | €31.20 Million ≈ $36.48 Million |
+13.32% |
| 2021-09-30 | €27.53 Million ≈ $32.19 Million |
-0.93% |
| 2020-09-30 | €27.79 Million ≈ $32.49 Million |
+16.18% |
| 2019-09-30 | €23.92 Million ≈ $27.96 Million |
-37.74% |
| 2018-09-30 | €38.42 Million ≈ $44.92 Million |
-21.72% |
| 2017-09-30 | €49.08 Million ≈ $57.38 Million |
+14.13% |
| 2016-09-30 | €43.00 Million ≈ $50.28 Million |
-5.59% |
| 2015-09-30 | €45.55 Million ≈ $53.25 Million |
+19.07% |
| 2014-09-30 | €38.25 Million ≈ $44.72 Million |
+11.29% |
| 2013-09-30 | €34.37 Million ≈ $40.19 Million |
+11.19% |
| 2012-09-30 | €30.91 Million ≈ $36.14 Million |
-5.02% |
| 2011-09-30 | €32.55 Million ≈ $38.05 Million |
-16.08% |
| 2010-09-30 | €38.78 Million ≈ $45.34 Million |
-23.88% |
| 2009-09-30 | €50.95 Million ≈ $59.57 Million |
-14.48% |
| 2008-09-30 | €59.58 Million ≈ $69.66 Million |
+67.49% |
| 2007-09-30 | €35.58 Million ≈ $41.59 Million |
+290.81% |
| 2006-09-30 | €9.10 Million ≈ $10.64 Million |
-- |
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more